Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD (Lp(a)HORIZON)

November 13, 2023 updated by: Novartis Pharmaceuticals

A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease

This is a pivotal phase 3 study designed to support an indication for the reduction of cardiovascular risk in patients with established CVD and elevated Lp(a)

Study Overview

Status

Active, not recruiting

Conditions

Cardiovascular Disease and Lipoprotein(a)

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

8323

Phase

Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Argentina
- - Buenos Aires, Argentina, C1430EGF
    - Novartis Investigative Site
  - Caba, Argentina, 1426
    - Novartis Investigative Site
  - Capital Federal, Argentina, C1023AAB
    - Novartis Investigative Site
  - Cordoba, Argentina, X5000EVQ
    - Novartis Investigative Site
  - Cordoba, Argentina, X5016KET
    - Novartis Investigative Site
  - Corrientes, Argentina, W3400
    - Novartis Investigative Site
  - San Luis, Argentina, D5702JRS
    - Novartis Investigative Site
  - Santa Fe, Argentina, S3000FWO
    - Novartis Investigative Site
- Buenos Aires
  - Caba, Buenos Aires, Argentina, C1280AEB
    - Novartis Investigative Site
  - Caba, Buenos Aires, Argentina, 1407
    - Novartis Investigative Site
  - Caba, Buenos Aires, Argentina, C1056ABJ
    - Novartis Investigative Site
  - Mar del Plata, Buenos Aires, Argentina, 7600
    - Novartis Investigative Site
  - Ramos Mejia, Buenos Aires, Argentina, B1704ETD
    - Novartis Investigative Site
- San Miguel De Tucuman
  - Tucuman, San Miguel De Tucuman, Argentina, T4000ICL
    - Novartis Investigative Site
- Santa Fe
  - Rosario, Santa Fe, Argentina, 2000
    - Novartis Investigative Site
  - Rosario, Santa Fe, Argentina, S200CVD
    - Novartis Investigative Site
- Tucuman
  - San Miguel de Tucuman, Tucuman, Argentina, T4000IFL
    - Novartis Investigative Site
Australia
- New South Wales
  - Camperdown, New South Wales, Australia, 2050
    - Novartis Investigative Site
  - Liverpool, New South Wales, Australia, 2170
    - Novartis Investigative Site
- Queensland
  - Chemside, Queensland, Australia, 4032
    - Novartis Investigative Site
  - Southport, Queensland, Australia, 4215
    - Novartis Investigative Site
  - Woolloongabba, Queensland, Australia, 4102
    - Novartis Investigative Site
- Victoria
  - Clayton, Victoria, Australia, 3168
    - Novartis Investigative Site
- Western Australia
  - Perth, Western Australia, Australia, 6000
    - Novartis Investigative Site
Austria
- - Graz, Austria, 8036
    - Novartis Investigative Site
  - Innsbruck, Austria, 6020
    - Novartis Investigative Site
  - Linz, Austria, 4021
    - Novartis Investigative Site
  - Salzburg, Austria, A-5020
    - Novartis Investigative Site
  - Wien, Austria, 1090
    - Novartis Investigative Site
  - Wien, Austria, 1210
    - Novartis Investigative Site
Belgium
- - Aalst, Belgium, 9300
    - Novartis Investigative Site
  - Brugge, Belgium, 8000
    - Novartis Investigative Site
  - Bruxelles, Belgium, 1070
    - Novartis Investigative Site
  - Dendermonde, Belgium, 9200
    - Novartis Investigative Site
  - Genk, Belgium, 3600
    - Novartis Investigative Site
  - Huy, Belgium, 4500
    - Novartis Investigative Site
  - Kortrijk, Belgium, 8500
    - Novartis Investigative Site
  - Mechelen, Belgium, 2800
    - Novartis Investigative Site
Brazil
- - Rio de Janeiro, Brazil, 20241-180
    - Novartis Investigative Site
  - Sao Paulo, Brazil, 05403-900
    - Novartis Investigative Site
- AL
  - Maceio, AL, Brazil, 57051-160
    - Novartis Investigative Site
- BA
  - Salvador, BA, Brazil, 40170-130
    - Novartis Investigative Site
- DF
  - Brasilia, DF, Brazil, 70390-903
    - Novartis Investigative Site
- ES
  - Vitoria, ES, Brazil, 29055-450
    - Novartis Investigative Site
- GO
  - Goiania, GO, Brazil, 74605-020
    - Novartis Investigative Site
- MG
  - Belo Horizonte, MG, Brazil, 30150-221
    - Novartis Investigative Site
  - Belo Horizonte, MG, Brazil, 30220330
    - Novartis Investigative Site
  - Juiz de Fora, MG, Brazil, 36033-318
    - Novartis Investigative Site
- Minas Gerais
  - Uberlandia, Minas Gerais, Brazil, 38400 500
    - Novartis Investigative Site
- PR
  - Curitiba, PR, Brazil, 80730-150
    - Novartis Investigative Site
- Parana
  - Curitiba, Parana, Brazil, 80230-130
    - Novartis Investigative Site
- RS
  - Canoas, RS, Brazil, 92425 900
    - Novartis Investigative Site
  - Porto Alegre, RS, Brazil, 90880-480
    - Novartis Investigative Site
  - Porto Alegre, RS, Brazil, 90160093
    - Novartis Investigative Site
- SE
  - Aracaju, SE, Brazil, 49055530
    - Novartis Investigative Site
- SP
  - Campinas, SP, Brazil, 13060 080
    - Novartis Investigative Site
  - Campinas, SP, Brazil, 13092-133
    - Novartis Investigative Site
  - Ribeirao Preto, SP, Brazil, 14026 020
    - Novartis Investigative Site
  - Santo Andre, SP, Brazil, 09060-870
    - Novartis Investigative Site
  - Santo Andre, SP, Brazil, 09090-790
    - Novartis Investigative Site
  - Sao Jose do Rio Preto, SP, Brazil, 15090 000
    - Novartis Investigative Site
  - Sao Jose do Rio Preto, SP, Brazil, 15015-750
    - Novartis Investigative Site
  - Sao Paulo, SP, Brazil, 05403 000
    - Novartis Investigative Site
  - Sao Paulo, SP, Brazil, 01141-020
    - Novartis Investigative Site
  - Sao Paulo, SP, Brazil, 01323 000
    - Novartis Investigative Site
  - Sao Paulo, SP, Brazil, 04005-003
    - Novartis Investigative Site
  - Sao Paulo, SP, Brazil, 04023-900
    - Novartis Investigative Site
  - Sao Paulo, SP, Brazil, 04266 010
    - Novartis Investigative Site
- Santa Catarina
  - Blumenau, Santa Catarina, Brazil, 89020 430
    - Novartis Investigative Site
Bulgaria
- - Blagoevgrad, Bulgaria, 2700
    - Novartis Investigative Site
  - Burgas, Bulgaria, 8000
    - Novartis Investigative Site
  - Pernik, Bulgaria, 2300
    - Novartis Investigative Site
  - Pleven, Bulgaria, 5800
    - Novartis Investigative Site
  - Plovdiv, Bulgaria, 4000
    - Novartis Investigative Site
  - Ruse, Bulgaria, 7002
    - Novartis Investigative Site
  - Sofia, Bulgaria, 1233
    - Novartis Investigative Site
  - Sofia, Bulgaria, 1709
    - Novartis Investigative Site
Canada
- - Quebec, Canada, G1R 2J6
    - Novartis Investigative Site
  - Quebec, Canada, G1V 4W2
    - Novartis Investigative Site
  - Quebec, Canada, G1V 4G2
    - Novartis Investigative Site
- British Columbia
  - Vancouver, British Columbia, Canada, V6Z 1Y6
    - Novartis Investigative Site
  - Vancouver, British Columbia, Canada, V5Z 1M9
    - Novartis Investigative Site
  - Victoria, British Columbia, Canada, V8R4R2
    - Novartis Investigative Site
  - Victoria, British Columbia, Canada, V8T 5G4
    - Novartis Investigative Site
- Ontario
  - Oakville, Ontario, Canada, L6K 3W7
    - Novartis Investigative Site
  - Toronto, Ontario, Canada, M9V 4B4
    - Novartis Investigative Site
- Quebec
  - Levis, Quebec, Canada, G6V 4Z5
    - Novartis Investigative Site
  - Montreal, Quebec, Canada, H4A 3J1
    - Novartis Investigative Site
  - Montreal, Quebec, Canada, H3T 1E2
    - Novartis Investigative Site
  - Montreal, Quebec, Canada, H1T 1C8
    - Novartis Investigative Site
  - Montreal, Quebec, Canada, H2X 0A9
    - Novartis Investigative Site
  - Sainte Foy, Quebec, Canada, G1V 4G5
    - Novartis Investigative Site
  - Terrebonne, Quebec, Canada, J6V 2H2
    - Novartis Investigative Site
Chile
- - Santiago, Chile, 7500710
    - Novartis Investigative Site
  - Santiago, Chile, 838 0456
    - Novartis Investigative Site
  - Santiago, Chile, 8320000
    - Novartis Investigative Site
- RM
  - Santiago, RM, Chile, 7500588
    - Novartis Investigative Site
  - Santiago, RM, Chile, 8380465
    - Novartis Investigative Site
- Region Metropolitana
  - Santiago, Region Metropolitana, Chile, 8331143
    - Novartis Investigative Site
China
- - Beijing, China, 100730
    - Novartis Investigative Site
  - Beijing, China, 100029
    - Novartis Investigative Site
  - Beijing, China, 100050
    - Novartis Investigative Site
  - Beijing, China, 100191
    - Novartis Investigative Site
  - Nanjing, China, 210036
    - Novartis Investigative Site
  - Shanghai, China, 200025
    - Novartis Investigative Site
  - Shanghai, China, 200040
    - Novartis Investigative Site
  - Shanghai, China, 200120
    - Novartis Investigative Site
  - Tianjin, China, 300052
    - Novartis Investigative Site
  - Tianjin, China, 30045
    - Novartis Investigative Site
  - Xiamen, China, 361004
    - Novartis Investigative Site
- Gansu
  - Lanzhou, Gansu, China, 730030
    - Novartis Investigative Site
- Guangdong
  - Foshan, Guangdong, China, 528000
    - Novartis Investigative Site
  - Guangzhou, Guangdong, China, 510080
    - Novartis Investigative Site
  - Guangzhou, Guangdong, China, 51000
    - Novartis Investigative Site
- Heilongjiang
  - Harbin, Heilongjiang, China, 150000
    - Novartis Investigative Site
- Hubei
  - Wuhan, Hubei, China, 430030
    - Novartis Investigative Site
- Hunan
  - Changsha, Hunan, China, 410011
    - Novartis Investigative Site
  - Changsha, Hunan, China, 410003
    - Novartis Investigative Site
- Inner Mongolia
  - Baotou, Inner Mongolia, China, 014040
    - Novartis Investigative Site
- Jiangsu
  - Nanjing, Jiangsu, China, 210009
    - Novartis Investigative Site
  - Nanjing, Jiangsu, China, 211166
    - Novartis Investigative Site
  - Suzhou, Jiangsu, China, 215006
    - Novartis Investigative Site
  - Xuzhou, Jiangsu, China, 221003
    - Novartis Investigative Site
- Jilin
  - Changchun, Jilin, China, 130022
    - Novartis Investigative Site
- Liaoning
  - Dalian, Liaoning, China, 116011
    - Novartis Investigative Site
  - Shenyang, Liaoning, China, 110003
    - Novartis Investigative Site
  - Shenyang, Liaoning, China, 110016
    - Novartis Investigative Site
- Shandong
  - Jinan, Shandong, China, 250013
    - Novartis Investigative Site
- Shanxi
  - Xian, Shanxi, China, 710061
    - Novartis Investigative Site
- Sichuan
  - Chengdu, Sichuan, China, 610041
    - Novartis Investigative Site
- Tianjin
  - Tianjin, Tianjin, China, 300121
    - Novartis Investigative Site
- Xinjiang
  - Wulumuqi, Xinjiang, China, 830054
    - Novartis Investigative Site
- Zhejiang
  - Hangzhou, Zhejiang, China, 310016
    - Novartis Investigative Site
  - Hangzhou, Zhejiang, China, 310014
    - Novartis Investigative Site
  - Wenzhou, Zhejiang, China, 325000
    - Novartis Investigative Site
Colombia
- - Barranquilla, Colombia, 080020
    - Novartis Investigative Site
  - Bogota, Colombia, 111611
    - Novartis Investigative Site
  - Medellin, Colombia, 050037
    - Novartis Investigative Site
  - San Gil, Colombia, 684031
    - Novartis Investigative Site
- Antioquia
  - Medellin, Antioquia, Colombia, 050001
    - Novartis Investigative Site
- Cundinamarca
  - Bogota, Cundinamarca, Colombia, 110911
    - Novartis Investigative Site
- Santander
  - Bucaramanga, Santander, Colombia, 65265
    - Novartis Investigative Site
- Valle Del Cauca
  - Cali, Valle Del Cauca, Colombia, 760001
    - Novartis Investigative Site
  - Cali, Valle Del Cauca, Colombia, 760012
    - Novartis Investigative Site
Czechia
- - Brno, Czechia, 60200
    - Novartis Investigative Site
  - Brno Bohunice, Czechia, 625 00
    - Novartis Investigative Site
  - Broumov, Czechia, 550 01
    - Novartis Investigative Site
  - CZE, Czechia, 11000
    - Novartis Investigative Site
  - Chlumec nad Cidlinou, Czechia, 50351
    - Novartis Investigative Site
  - Hlucin, Czechia, 748 01
    - Novartis Investigative Site
  - Hodonin, Czechia, 69501
    - Novartis Investigative Site
  - JIhlava, Czechia, 586 01
    - Novartis Investigative Site
  - Kolin, Czechia, 280 20
    - Novartis Investigative Site
  - Liberec, Czechia, 460 01
    - Novartis Investigative Site
  - Marianske lazne, Czechia, 353 01
    - Novartis Investigative Site
  - Melnik, Czechia, 27601
    - Novartis Investigative Site
  - Olomouc, Czechia, 77900
    - Novartis Investigative Site
  - Ostrava, Czechia, 700 30
    - Novartis Investigative Site
  - Ostrava, Czechia, 70030
    - Novartis Investigative Site
  - Ostrava, Czechia, 71000
    - Novartis Investigative Site
  - Praha, Czechia, 12808
    - Novartis Investigative Site
  - Praha, Czechia, 101 00
    - Novartis Investigative Site
  - Praha, Czechia, 110 00
    - Novartis Investigative Site
  - Praha 5, Czechia, 158 00
    - Novartis Investigative Site
  - Prerov, Czechia, 751 52
    - Novartis Investigative Site
  - Slany, Czechia, 27401
    - Novartis Investigative Site
  - Uherske Hradiste, Czechia, 68601
    - Novartis Investigative Site
  - Valasske Mezirici, Czechia, 75742
    - Novartis Investigative Site
  - Zlin, Czechia, 76001
    - Novartis Investigative Site
- CZE
  - Most, CZE, Czechia, 434 01
    - Novartis Investigative Site
  - Policska, CZE, Czechia, 57201
    - Novartis Investigative Site
  - Trutnov, CZE, Czechia, 46063
    - Novartis Investigative Site
- Czech Republic
  - Brandys nad Labem, Czech Republic, Czechia, 250 01
    - Novartis Investigative Site
  - Brno, Czech Republic, Czechia, 656 91
    - Novartis Investigative Site
  - Brno, Czech Republic, Czechia, 60200
    - Novartis Investigative Site
  - Cesky Krumlov, Czech Republic, Czechia, 381 01
    - Novartis Investigative Site
  - Kromeriz, Czech Republic, Czechia, 767 55
    - Novartis Investigative Site
  - Liberec V Kristianova, Czech Republic, Czechia, 460 05
    - Novartis Investigative Site
  - Louny, Czech Republic, Czechia, 440 01
    - Novartis Investigative Site
  - Ostrava, Czech Republic, Czechia, 70200
    - Novartis Investigative Site
  - Pardubice, Czech Republic, Czechia, 532 03
    - Novartis Investigative Site
  - Svitavy, Czech Republic, Czechia, 568 25
    - Novartis Investigative Site
  - Trebic, Czech Republic, Czechia, 674 01
    - Novartis Investigative Site
  - Usti nad Labem, Czech Republic, Czechia, 400 01
    - Novartis Investigative Site
Denmark
- - Aalborg, Denmark, 9000
    - Novartis Investigative Site
  - Arhus N, Denmark, DK-8200
    - Novartis Investigative Site
  - Esbjerg, Denmark, DK-6700
    - Novartis Investigative Site
  - Glostrup, Denmark, 2600
    - Novartis Investigative Site
  - Herlev, Denmark, DK 2730
    - Novartis Investigative Site
  - Roskilde, Denmark, 4000
    - Novartis Investigative Site
  - Viborg, Denmark, DK-8800
    - Novartis Investigative Site
France
- - Bron, France, 69677
    - Novartis Investigative Site
  - Chambray les Tours, France, 37170
    - Novartis Investigative Site
  - Compiègne, France, 60321
    - Novartis Investigative Site
  - Grenoble Cedex 9, France, 38043
    - Novartis Investigative Site
  - Le Coudray, France, 28630
    - Novartis Investigative Site
  - Lille, France, 59037
    - Novartis Investigative Site
  - Paris, France, 75015
    - Novartis Investigative Site
  - Paris, France, 75012
    - Novartis Investigative Site
  - Paris, France, 75018
    - Novartis Investigative Site
  - St Herblain, France, 44800
    - Novartis Investigative Site
  - Toulouse 4, France, 31054
    - Novartis Investigative Site
  - Tourcoing, France, 59200
    - Novartis Investigative Site
  - Valenciennes, France, 59300
    - Novartis Investigative Site
Germany
- - Aachen, Germany, 52074
    - Novartis Investigative Site
  - Bad Homburg, Germany, 61348
    - Novartis Investigative Site
  - Bad Krozingen, Germany, 79189
    - Novartis Investigative Site
  - Bad Oeynhausen, Germany, 32545
    - Novartis Investigative Site
  - Bamberg, Germany, 96049
    - Novartis Investigative Site
  - Berlin, Germany, 10367
    - Novartis Investigative Site
  - Berlin, Germany, 13353
    - Novartis Investigative Site
  - Berlin, Germany, 10787
    - Novartis Investigative Site
  - Berlin, Germany, 10789
    - Novartis Investigative Site
  - Berlin, Germany, 13347
    - Novartis Investigative Site
  - Berlin, Germany, D 10559
    - Novartis Investigative Site
  - Bielefeld, Germany, 33604
    - Novartis Investigative Site
  - Chemnitz, Germany, 09122
    - Novartis Investigative Site
  - Dessau-Roßlau, Germany, 06846
    - Novartis Investigative Site
  - Dortmund, Germany, 44137
    - Novartis Investigative Site
  - Dresden, Germany, 01307
    - Novartis Investigative Site
  - Dresden, Germany, 01277
    - Novartis Investigative Site
  - Dresden, Germany, 01069
    - Novartis Investigative Site
  - Essen, Germany, 45277
    - Novartis Investigative Site
  - Essen, Germany, 45355
    - Novartis Investigative Site
  - Essen, Germany, 45359
    - Novartis Investigative Site
  - Frankfurt, Germany, 60590
    - Novartis Investigative Site
  - Frankfurt, Germany, 60594
    - Novartis Investigative Site
  - Gelnhausen, Germany, 63571
    - Novartis Investigative Site
  - Hamburg, Germany, 22041
    - Novartis Investigative Site
  - Hamburg, Germany, 22607
    - Novartis Investigative Site
  - Jena, Germany, 07740
    - Novartis Investigative Site
  - Kassel, Germany, 34121
    - Novartis Investigative Site
  - Koeln, Germany, 50937
    - Novartis Investigative Site
  - Koeln-Nippes, Germany, 50733
    - Novartis Investigative Site
  - Kuenzing, Germany, 94550
    - Novartis Investigative Site
  - Leipzig, Germany, 04103
    - Novartis Investigative Site
  - Loehne, Germany, 32584
    - Novartis Investigative Site
  - Lutherstadt Wittenberg, Germany, 06886
    - Novartis Investigative Site
  - Lüneburg, Germany, 21339
    - Novartis Investigative Site
  - Magdeburg, Germany, 39120
    - Novartis Investigative Site
  - Mannheim, Germany, 68165
    - Novartis Investigative Site
  - Meißen, Germany, 01662
    - Novartis Investigative Site
  - Muehldorf, Germany, 84453
    - Novartis Investigative Site
  - Muenchen, Germany, 81377
    - Novartis Investigative Site
  - Muenchen, Germany, 80636
    - Novartis Investigative Site
  - Muenster, Germany, 48149
    - Novartis Investigative Site
  - Potsdam, Germany, 14471
    - Novartis Investigative Site
  - Rüdersdorf, Germany, 15562
    - Novartis Investigative Site
  - Saint Ingbert - Oberwuerzbach, Germany, 66386
    - Novartis Investigative Site
  - Ulm, Germany, 89077
    - Novartis Investigative Site
  - Warendorf, Germany, 48231
    - Novartis Investigative Site
  - Weiden, Germany, 92637
    - Novartis Investigative Site
- Baden Wuerttemberg
  - Mannheim, Baden Wuerttemberg, Germany, 68305
    - Novartis Investigative Site
- Niedersachsen
  - Hannover, Niedersachsen, Germany, 30159
    - Novartis Investigative Site
- Sachsen
  - Bad Gottleuba, Sachsen, Germany, 01816
    - Novartis Investigative Site
  - Dresden, Sachsen, Germany, 01099
    - Novartis Investigative Site
  - Leipzig, Sachsen, Germany, 04315
    - Novartis Investigative Site
- Saxony
  - Chemnitz, Saxony, Germany, 09113
    - Novartis Investigative Site
Greece
- - Athens, Greece, 115 27
    - Novartis Investigative Site
  - Athens, Greece, 115 21
    - Novartis Investigative Site
  - Chalkida, Greece, GR 341 00
    - Novartis Investigative Site
  - Thessaloniki, Greece, GR 54636
    - Novartis Investigative Site
- GR
  - Athens, GR, Greece, 14233
    - Novartis Investigative Site
  - Ioannina, GR, Greece, 455 00
    - Novartis Investigative Site
  - Larissa, GR, Greece, 411 10
    - Novartis Investigative Site
Guatemala
- - Guatemala, Guatemala, 01010
    - Novartis Investigative Site
  - Guatemala, Guatemala, 01001
    - Novartis Investigative Site
  - Guatemala, Guatemala, 01011
    - Novartis Investigative Site
  - Guatemala City, Guatemala, 01010
    - Novartis Investigative Site
  - Guatemala City, Guatemala, 01001
    - Novartis Investigative Site
  - Guatemala City, Guatemala, 01011
    - Novartis Investigative Site
Hong Kong
- - Hong Kong, Hong Kong, HONG KONG
    - Novartis Investigative Site
  - Hongkong, Hong Kong
    - Novartis Investigative Site
Hungary
- - Baja, Hungary, 6500
    - Novartis Investigative Site
  - Budapest, Hungary, 1145
    - Novartis Investigative Site
  - Budapest, Hungary, 1085
    - Novartis Investigative Site
  - Budapest, Hungary, H-1097
    - Novartis Investigative Site
  - Debrecen, Hungary, 4032
    - Novartis Investigative Site
  - Kistarcsa, Hungary, 2143
    - Novartis Investigative Site
  - Mako, Hungary, 6900
    - Novartis Investigative Site
  - Mateszalka, Hungary, 4700
    - Novartis Investigative Site
  - Miskolc, Hungary, 3526
    - Novartis Investigative Site
  - Nyiregyhaza, Hungary, 4400
    - Novartis Investigative Site
  - Szeged, Hungary, 6720
    - Novartis Investigative Site
- Baranya
  - Pecs, Baranya, Hungary, 7621
    - Novartis Investigative Site
  - Pecs, Baranya, Hungary, 7624
    - Novartis Investigative Site
- Fejer
  - Szekesfehervar, Fejer, Hungary, H-8000
    - Novartis Investigative Site
- HUN
  - Budapest, HUN, Hungary, 1204
    - Novartis Investigative Site
Iceland
- - Kopavogur, Iceland, 201
    - Novartis Investigative Site
  - Reykjavik, Iceland, IS-101
    - Novartis Investigative Site
India
- - Belagavi, India, 590010
    - Novartis Investigative Site
  - Coimbatore, India, 641 009
    - Novartis Investigative Site
  - New Delhi, India, 110025
    - Novartis Investigative Site
  - New Delhi, India, 110075
    - Novartis Investigative Site
- Andhra Pradesh
  - Hyderabad, Andhra Pradesh, India, 500033
    - Novartis Investigative Site
- Andhrapradesh
  - Guntur, Andhrapradesh, India, 522001
    - Novartis Investigative Site
- Delhi
  - New Delhi, Delhi, India, 110 060
    - Novartis Investigative Site
- Gujarat
  - Ahmedabad, Gujarat, India, 380 060
    - Novartis Investigative Site
  - Vadodara, Gujarat, India, 390022
    - Novartis Investigative Site
- Gujrat
  - Ahmedabad, Gujrat, India, 380060
    - Novartis Investigative Site
- Karnataka
  - Bengaluru, Karnataka, India, 560024
    - Novartis Investigative Site
  - Mangalore, Karnataka, India, 575018
    - Novartis Investigative Site
  - Manipal, Karnataka, India, 576104
    - Novartis Investigative Site
- Kerala
  - Kochi, Kerala, India, 682027
    - Novartis Investigative Site
  - Kochi, Kerala, India, 682 018
    - Novartis Investigative Site
  - Kochi, Kerala, India, 682041
    - Novartis Investigative Site
  - Kozhikode, Kerala, India, 673008
    - Novartis Investigative Site
- Maharashtra
  - Mumbai, Maharashtra, India, 401107
    - Novartis Investigative Site
  - Nagpur, Maharashtra, India, 440009
    - Novartis Investigative Site
  - Nagpur, Maharashtra, India, 440008
    - Novartis Investigative Site
  - Nagpur, Maharashtra, India, 440012
    - Novartis Investigative Site
  - Nagpur, Maharashtra, India, 440033
    - Novartis Investigative Site
  - Nashik, Maharashtra, India, 422 005
    - Novartis Investigative Site
  - Pune, Maharashtra, India, 411004
    - Novartis Investigative Site
  - Pune, Maharashtra, India, 411001
    - Novartis Investigative Site
  - Pune, Maharashtra, India, 411045
    - Novartis Investigative Site
- Rajasthan
  - Bikaner, Rajasthan, India, 334003
    - Novartis Investigative Site
- Tamil Nadu
  - Chennai, Tamil Nadu, India, 600081
    - Novartis Investigative Site
  - Coimbatore, Tamil Nadu, India, 641037
    - Novartis Investigative Site
- Telangana
  - Hyderabad, Telangana, India, 500082
    - Novartis Investigative Site
  - Hyderabad, Telangana, India, 500034
    - Novartis Investigative Site
  - Secunderabad, Telangana, India, 500003
    - Novartis Investigative Site
- Uttar Pradesh
  - Ghaziabad, Uttar Pradesh, India, 110093
    - Novartis Investigative Site
  - Lucknow, Uttar Pradesh, India, 226003
    - Novartis Investigative Site
  - Varanasi, Uttar Pradesh, India, 221010
    - Novartis Investigative Site
- Uttarakhand
  - DehraDun, Uttarakhand, India, 248001
    - Novartis Investigative Site
Israel
- - Beer-Sheva, Israel, 8457108
    - Novartis Investigative Site
  - Haifa, Israel, 3339419
    - Novartis Investigative Site
  - Haifa, Israel, 3436212
    - Novartis Investigative Site
  - Jerusalem, Israel, 9112001
    - Novartis Investigative Site
  - Petach Tikva, Israel, 4941492
    - Novartis Investigative Site
  - Ramat Gan, Israel, 52621
    - Novartis Investigative Site
  - Tel Giborim, Holon, Israel, 58100
    - Novartis Investigative Site
Italy
- - Napoli, Italy, 80131
    - Novartis Investigative Site
- AN
  - Ancona, AN, Italy, 60128
    - Novartis Investigative Site
- BG
  - Bergamo, BG, Italy, 24127
    - Novartis Investigative Site
- BO
  - Bologna, BO, Italy, 40138
    - Novartis Investigative Site
- BS
  - Brescia, BS, Italy, 25123
    - Novartis Investigative Site
- FE
  - Cona, FE, Italy, 44100
    - Novartis Investigative Site
- FI
  - Firenze, FI, Italy, 50134
    - Novartis Investigative Site
- IS
  - Pozzilli, IS, Italy, 86077
    - Novartis Investigative Site
- MI
  - Milano, MI, Italy, 20162
    - Novartis Investigative Site
  - Milano, MI, Italy, 20132
    - Novartis Investigative Site
  - Milano, MI, Italy, 20149
    - Novartis Investigative Site
  - Milano, MI, Italy, 20138
    - Novartis Investigative Site
  - Rozzano, MI, Italy, 20089
    - Novartis Investigative Site
- PA
  - Palermo, PA, Italy, 90127
    - Novartis Investigative Site
- PG
  - Perugia, PG, Italy, 06129
    - Novartis Investigative Site
- PI
  - Pisa, PI, Italy, 56124
    - Novartis Investigative Site
  - Pisa, PI, Italy, 56126
    - Novartis Investigative Site
- RM
  - Roma, RM, Italy, 00189
    - Novartis Investigative Site
  - Roma, RM, Italy, 00100
    - Novartis Investigative Site
- SA
  - Salerno, SA, Italy, 84131
    - Novartis Investigative Site
- VA
  - Varese, VA, Italy, 21100
    - Novartis Investigative Site
Japan
- Aichi
  - Nagoya, Aichi, Japan, 453-8511
    - Novartis Investigative Site
  - Seto-city, Aichi, Japan, 489-8642
    - Novartis Investigative Site
- Aomori
  - Hirosaki, Aomori, Japan, 036 8563
    - Novartis Investigative Site
- Chiba
  - Asahi, Chiba, Japan, 289-2511
    - Novartis Investigative Site
  - Funabashi, Chiba, Japan, 273-8588
    - Novartis Investigative Site
  - Matsudo-city, Chiba, Japan, 270-2251
    - Novartis Investigative Site
- Fukuoka
  - Fukuoka city, Fukuoka, Japan, 814 0180
    - Novartis Investigative Site
  - Kitakyushu-city, Fukuoka, Japan, 802-8555
    - Novartis Investigative Site
- Gifu
  - Ogaki-city, Gifu, Japan, 503-8502
    - Novartis Investigative Site
- Hiroshima
  - Kure-city, Hiroshima, Japan, 737-0023
    - Novartis Investigative Site
- Ibaraki
  - Tsuchiura, Ibaraki, Japan, 300-0028
    - Novartis Investigative Site
- Ishikawa
  - Kahoku-gun, Ishikawa, Japan, 920-0293
    - Novartis Investigative Site
  - Kanazawa-city, Ishikawa, Japan, 920-8641
    - Novartis Investigative Site
  - Komatsu, Ishikawa, Japan, 923-0961
    - Novartis Investigative Site
- Kagawa
  - Takamatsu city, Kagawa, Japan, 760 8557
    - Novartis Investigative Site
- Kanagawa
  - Kawasaki, Kanagawa, Japan, 212-0021
    - Novartis Investigative Site
  - Sagamihara, Kanagawa, Japan, 252-0375
    - Novartis Investigative Site
  - Yokohama city, Kanagawa, Japan, 232 0024
    - Novartis Investigative Site
  - Yokohama-city, Kanagawa, Japan, 236 0037
    - Novartis Investigative Site
- Miyagi
  - Sendai city, Miyagi, Japan, 980 0873
    - Novartis Investigative Site
- Miyazaki
  - Miyhazaki-city, Miyazaki, Japan, 880-2102
    - Novartis Investigative Site
- Niigata
  - Nagaoka-city, Niigata, Japan, 940-8621
    - Novartis Investigative Site
- Osaka
  - Osaka city, Osaka, Japan, 530 0001
    - Novartis Investigative Site
  - Osaka-city, Osaka, Japan, 543-0035
    - Novartis Investigative Site
- Saitama
  - Kawaguchi-city, Saitama, Japan, 333-0842
    - Novartis Investigative Site
  - Sayama-city, Saitama, Japan, 350-1305
    - Novartis Investigative Site
- Shiga
  - Omihachiman, Shiga, Japan, 523-0082
    - Novartis Investigative Site
- Tokyo
  - Bunkyo ku, Tokyo, Japan, 113-8431
    - Novartis Investigative Site
  - Chuo ku, Tokyo, Japan, 104-8560
    - Novartis Investigative Site
  - Chuo-ku, Tokyo, Japan, 103-0027
    - Novartis Investigative Site
  - Hachioji-city, Tokyo, Japan, 192-0918
    - Novartis Investigative Site
  - Itabashi-ku, Tokyo, Japan, 173-8610
    - Novartis Investigative Site
  - Ota-ku, Tokyo, Japan, 143 8541
    - Novartis Investigative Site
  - Shinagawa-ku, Tokyo, Japan, 142-8666
    - Novartis Investigative Site
  - Toshima-ku, Tokyo, Japan, 171-0014
    - Novartis Investigative Site
Korea, Republic of
- - Busan, Korea, Republic of, 49201
    - Novartis Investigative Site
  - Gwangju, Korea, Republic of, 61469
    - Novartis Investigative Site
  - Incheon, Korea, Republic of, 405 760
    - Novartis Investigative Site
  - Seoul, Korea, Republic of, 03080
    - Novartis Investigative Site
  - Seoul, Korea, Republic of, 02841
    - Novartis Investigative Site
- Dalseo Gu
  - Daegu, Dalseo Gu, Korea, Republic of, 42602
    - Novartis Investigative Site
- Gangwon-Do
  - Wonju, Gangwon-Do, Korea, Republic of, 26426
    - Novartis Investigative Site
- Gyeonggi Do
  - Bundang Gu, Gyeonggi Do, Korea, Republic of, 13620
    - Novartis Investigative Site
  - Suwon si, Gyeonggi Do, Korea, Republic of, 16499
    - Novartis Investigative Site
- KOR
  - Seoul, KOR, Korea, Republic of, 03181
    - Novartis Investigative Site
- Korea
  - Seoul, Korea, Korea, Republic of, 08308
    - Novartis Investigative Site
- Seocho Gu
  - Seoul, Seocho Gu, Korea, Republic of, 06591
    - Novartis Investigative Site
Mexico
- - Aguascalientes, Mexico, 20230
    - Novartis Investigative Site
  - Culiacan Sinaloa, Mexico, 80230
    - Novartis Investigative Site
  - Distrito Federal, Mexico, 14080
    - Novartis Investigative Site
  - San Luis Potosi, Mexico, 78200
    - Novartis Investigative Site
- Morelos
  - Cuernavaca, Morelos, Mexico, 62250
    - Novartis Investigative Site
Netherlands
- - Alkmaar, Netherlands, 1815 JD
    - Novartis Investigative Site
  - Amersfoort, Netherlands, 3813 TZ
    - Novartis Investigative Site
  - Amsterdam, Netherlands, 1090 HM
    - Novartis Investigative Site
  - Amsterdam, Netherlands, 1105 AZ
    - Novartis Investigative Site
  - Delft, Netherlands, 2625 AD
    - Novartis Investigative Site
  - Den Haag, Netherlands, 2545 CH
    - Novartis Investigative Site
  - Deventer, Netherlands, 7416 SE
    - Novartis Investigative Site
  - Enschede, Netherlands, 7512KZ
    - Novartis Investigative Site
  - Gouda, Netherlands, 2803 HH
    - Novartis Investigative Site
  - Groningen, Netherlands, 9728 NZ
    - Novartis Investigative Site
  - Hardenberg, Netherlands, 7770 AA
    - Novartis Investigative Site
  - Heemstede, Netherlands, 2102 CW
    - Novartis Investigative Site
  - Heerlen, Netherlands, 6419
    - Novartis Investigative Site
  - Leiden, Netherlands, 2300 RC
    - Novartis Investigative Site
  - Leiderdorp, Netherlands, 2353 GA
    - Novartis Investigative Site
  - Nijmegen, Netherlands, 6500 HB
    - Novartis Investigative Site
  - Nijmegen, Netherlands, 6532 SZ
    - Novartis Investigative Site
  - Tiel, Netherlands, 4002 WP
    - Novartis Investigative Site
  - Tilburg, Netherlands, 5042 AD
    - Novartis Investigative Site
  - Utrecht, Netherlands, 3584 CX
    - Novartis Investigative Site
  - Venlo, Netherlands, 5912 BL
    - Novartis Investigative Site
  - Zwolle, Netherlands, 8025 AB
    - Novartis Investigative Site
- DZ
  - Apeldoorn, DZ, Netherlands, 7334
    - Novartis Investigative Site
- Gelderland
  - Arnhem, Gelderland, Netherlands, 6815 AD
    - Novartis Investigative Site
- The Netherlands
  - Sneek, The Netherlands, Netherlands, 8601 ZR
    - Novartis Investigative Site
Norway
- - Oslo, Norway, 0514
    - Novartis Investigative Site
  - Skedsmokorset, Norway, 2020
    - Novartis Investigative Site
Peru
- Lima
  - San Miguel, Lima, Peru, 32
    - Novartis Investigative Site
Poland
- - Bielsko-Biala, Poland, 43-300
    - Novartis Investigative Site
  - Chrzanow, Poland, 32-500
    - Novartis Investigative Site
  - Gdansk, Poland, 80 952
    - Novartis Investigative Site
  - Gdynia, Poland, 81-157
    - Novartis Investigative Site
  - Kedzierzyn Kozle, Poland, 47 220
    - Novartis Investigative Site
  - Krakow, Poland, 30-082
    - Novartis Investigative Site
  - Krakow, Poland, 31 216
    - Novartis Investigative Site
  - Lodz, Poland, 93-338
    - Novartis Investigative Site
  - Lodz, Poland, 91-347
    - Novartis Investigative Site
  - Poznan, Poland, 60-589
    - Novartis Investigative Site
- Malopolskie
  - Tarnow, Malopolskie, Poland, 33-100
    - Novartis Investigative Site
- Mazowieckie
  - Warszawa, Mazowieckie, Poland, 00-892
    - Novartis Investigative Site
Portugal
- - Coimbra, Portugal, 3000 075
    - Novartis Investigative Site
  - Guimaraes, Portugal, 4835-044
    - Novartis Investigative Site
  - Setubal, Portugal, 2910-446
    - Novartis Investigative Site
Puerto Rico
- - Ponce, Puerto Rico, 00717-1322
    - Novartis Investigative Site
Romania
- - Baia Mare, Romania, 430123
    - Novartis Investigative Site
  - Baia Mare, Romania, 430222
    - Novartis Investigative Site
  - Brasov, Romania, 500283
    - Novartis Investigative Site
  - Bucharest, Romania, 050098
    - Novartis Investigative Site
  - Bucuresti, Romania, 062272
    - Novartis Investigative Site
  - Buzau, Romania, 120133
    - Novartis Investigative Site
  - Iasi, Romania, 700503
    - Novartis Investigative Site
- Jud Dolj
  - Craiova, Jud Dolj, Romania, 200513
    - Novartis Investigative Site
- Jud Iasi
  - Iasi, Jud Iasi, Romania, 700732
    - Novartis Investigative Site
- Timis
  - Timisoara, Timis, Romania, 300362
    - Novartis Investigative Site
Russian Federation
- - Chelyabinsk, Russian Federation, 454047
    - Novartis Investigative Site
  - Ekaterinburg, Russian Federation, 620028
    - Novartis Investigative Site
  - Ekaterinburg, Russian Federation, 620137
    - Novartis Investigative Site
  - Ivanovo, Russian Federation, 153012
    - Novartis Investigative Site
  - Izhevsk, Russian Federation, 426061
    - Novartis Investigative Site
  - Kemerovo, Russian Federation, 650002
    - Novartis Investigative Site
  - Kirov, Russian Federation, 610035
    - Novartis Investigative Site
  - Korolev Moscow Region, Russian Federation, 141060
    - Novartis Investigative Site
  - Krasnodar, Russian Federation, 350086
    - Novartis Investigative Site
  - Moscow, Russian Federation, 117198
    - Novartis Investigative Site
  - Moscow, Russian Federation, 127473
    - Novartis Investigative Site
  - Moscow, Russian Federation, 121552
    - Novartis Investigative Site
  - Moscow, Russian Federation, 101990
    - Novartis Investigative Site
  - Moscow, Russian Federation, 117997
    - Novartis Investigative Site
  - Moscow, Russian Federation, 143420
    - Novartis Investigative Site
  - Novosibirsk, Russian Federation, 630090
    - Novartis Investigative Site
  - Perm, Russian Federation, 614097
    - Novartis Investigative Site
  - Petrozavodsk, Russian Federation, 185019
    - Novartis Investigative Site
  - Rostov On Don, Russian Federation, 344022
    - Novartis Investigative Site
  - Ryazan, Russian Federation, 390039
    - Novartis Investigative Site
  - Saint Petersburg, Russian Federation, 197341
    - Novartis Investigative Site
  - Saint Petersburg, Russian Federation, 194354
    - Novartis Investigative Site
  - Saint Petersburg, Russian Federation, 195067
    - Novartis Investigative Site
  - Saint Petersburg, Russian Federation, 195197
    - Novartis Investigative Site
  - Saint Petersburg, Russian Federation, 198328
    - Novartis Investigative Site
  - Saint-Petersburg, Russian Federation, 196143
    - Novartis Investigative Site
  - Samara, Russian Federation, 443070
    - Novartis Investigative Site
  - Saratov, Russian Federation, 410028
    - Novartis Investigative Site
  - Saratov, Russian Federation, 410012
    - Novartis Investigative Site
  - Sochy, Russian Federation, 354002
    - Novartis Investigative Site
  - St Petersburg, Russian Federation, 192007
    - Novartis Investigative Site
  - St Petersburg, Russian Federation, 195197
    - Novartis Investigative Site
  - St Petersburg, Russian Federation, 196084
    - Novartis Investigative Site
  - St Petersburg, Russian Federation, 197136
    - Novartis Investigative Site
  - St.- Petersburg, Russian Federation, 197110
    - Novartis Investigative Site
  - Tomsk, Russian Federation, 634009
    - Novartis Investigative Site
  - Ulyanovsk, Russian Federation, 432063
    - Novartis Investigative Site
  - Vsevolozhsk, Russian Federation, 188640
    - Novartis Investigative Site
  - Yaroslavl, Russian Federation, 150062
    - Novartis Investigative Site
  - Yekaterinburg, Russian Federation, 620109
    - Novartis Investigative Site
Slovakia
- - Bardejov, Slovakia, 085 01
    - Novartis Investigative Site
  - Bardejov, Slovakia, 08501
    - Novartis Investigative Site
  - Bratislava, Slovakia, 833 48
    - Novartis Investigative Site
  - Bratislava, Slovakia, 85107
    - Novartis Investigative Site
  - Bratislava, Slovakia, 821 07
    - Novartis Investigative Site
  - Bratislava, Slovakia, 833 05
    - Novartis Investigative Site
  - Bratislava, Slovakia, 841 07
    - Novartis Investigative Site
  - Bratislava, Slovakia, 85101
    - Novartis Investigative Site
  - Brezno, Slovakia, 97701
    - Novartis Investigative Site
  - Dolny Kubin, Slovakia, 026 01
    - Novartis Investigative Site
  - Komarno, Slovakia, 94501
    - Novartis Investigative Site
  - Kosice, Slovakia, 040 01
    - Novartis Investigative Site
  - Lucenec, Slovakia, 98439
    - Novartis Investigative Site
  - Nitra, Slovakia, 949 01
    - Novartis Investigative Site
  - Nitra, Slovakia, 94901
    - Novartis Investigative Site
  - Nitra, Slovakia, 950 01
    - Novartis Investigative Site
  - Nove Zamky, Slovakia, 940 01
    - Novartis Investigative Site
  - Nove Zamky, Slovakia, 94002
    - Novartis Investigative Site
  - Piestany, Slovakia, 921 01
    - Novartis Investigative Site
  - Povazska Bystrica, Slovakia, 01701
    - Novartis Investigative Site
  - Presov, Slovakia, 080 01
    - Novartis Investigative Site
  - Presov, Slovakia, 08001
    - Novartis Investigative Site
  - Rimavska Sobota, Slovakia, 97901
    - Novartis Investigative Site
  - Svidnik, Slovakia, 089 01
    - Novartis Investigative Site
  - Trnava, Slovakia, 917 75
    - Novartis Investigative Site
- Bardejov
  - Bardejovske Kupele, Bardejov, Slovakia, 085 01
    - Novartis Investigative Site
- Okr Turcianske Teplice
  - Turcianske Teplice, Okr Turcianske Teplice, Slovakia, 03901
    - Novartis Investigative Site
- SVK
  - Handlova, SVK, Slovakia, 97251
    - Novartis Investigative Site
- Slovak Republic
  - Banska Bystrica, Slovak Republic, Slovakia, 974 01
    - Novartis Investigative Site
  - Komarno, Slovak Republic, Slovakia, 94501
    - Novartis Investigative Site
  - Kosice, Slovak Republic, Slovakia, 040 22
    - Novartis Investigative Site
  - Nitra, Slovak Republic, Slovakia, 949 01
    - Novartis Investigative Site
  - Rimavska Sobota, Slovak Republic, Slovakia, 97901
    - Novartis Investigative Site
  - Roznava, Slovak Republic, Slovakia, 04801
    - Novartis Investigative Site
- Zilinsky Kraj
  - Zilina, Zilinsky Kraj, Slovakia, 010 01
    - Novartis Investigative Site
Slovenia
- - Ljubljana, Slovenia, 1000
    - Novartis Investigative Site
South Africa
- - Cape Town, South Africa, 7925
    - Novartis Investigative Site
  - Cape Town, South Africa, 7405
    - Novartis Investigative Site
  - Cape Town, South Africa, 6665
    - Novartis Investigative Site
- Gauteng
  - Soweto, Gauteng, South Africa, 2013
    - Novartis Investigative Site
- Western Cape
  - Cape Town, Western Cape, South Africa, 7500
    - Novartis Investigative Site
  - George, Western Cape, South Africa, 6529
    - Novartis Investigative Site
Spain
- - A Coruna, Spain, 15001
    - Novartis Investigative Site
  - Barcelona, Spain, 08025
    - Novartis Investigative Site
  - Huelva, Spain, 21007
    - Novartis Investigative Site
  - Madrid, Spain, 28041
    - Novartis Investigative Site
  - Madrid, Spain, 28040
    - Novartis Investigative Site
  - Zaragoza, Spain, 50009
    - Novartis Investigative Site
- Andalucia
  - Cordoba, Andalucia, Spain, 14004
    - Novartis Investigative Site
  - Malaga, Andalucia, Spain, 29010
    - Novartis Investigative Site
  - Sevilla, Andalucia, Spain, 41013
    - Novartis Investigative Site
  - Sevilla, Andalucia, Spain, 41009
    - Novartis Investigative Site
  - Sevilla, Andalucia, Spain, 41014
    - Novartis Investigative Site
- Barcelona
  - Hospitalet de Llobregat, Barcelona, Spain, 08907
    - Novartis Investigative Site
- Cantabria
  - Santander, Cantabria, Spain, 39008
    - Novartis Investigative Site
- Cataluna
  - Reus, Cataluna, Spain, 43201
    - Novartis Investigative Site
- Catalunya
  - Badalona, Catalunya, Spain, 08916
    - Novartis Investigative Site
  - Barcelona, Catalunya, Spain, 08036
    - Novartis Investigative Site
- Comunidad Valenciana
  - Valencia, Comunidad Valenciana, Spain, 46010
    - Novartis Investigative Site
- Extremadura
  - Caceres, Extremadura, Spain, 10003
    - Novartis Investigative Site
- Galicia
  - Santiago de Compostela, Galicia, Spain, 15706
    - Novartis Investigative Site
Sweden
- - Goethenburg, Sweden, 413 45
    - Novartis Investigative Site
  - Lund, Sweden, 22221
    - Novartis Investigative Site
  - Stockholm, Sweden, 14186
    - Novartis Investigative Site
Switzerland
- - Basel, Switzerland, 4031
    - Novartis Investigative Site
  - Bern, Switzerland, 3010
    - Novartis Investigative Site
  - Geneve 14, Switzerland, 1211
    - Novartis Investigative Site
  - Lausanne, Switzerland, 1011
    - Novartis Investigative Site
  - Liestal, Switzerland, 4410
    - Novartis Investigative Site
  - Zuerich, Switzerland, 8091
    - Novartis Investigative Site
Taiwan
- - Hsinchu, Taiwan, 30069
    - Novartis Investigative Site
  - Kaohsiung, Taiwan, 80756
    - Novartis Investigative Site
  - Kaohsiung, Taiwan, 83301
    - Novartis Investigative Site
  - Keelung City, Taiwan, 20401
    - Novartis Investigative Site
  - Tainan, Taiwan, 71004
    - Novartis Investigative Site
  - Taipei, Taiwan, 11217
    - Novartis Investigative Site
  - Taoyuan, Taiwan, 33305
    - Novartis Investigative Site
  - Yilan, Taiwan, 26058
    - Novartis Investigative Site
- Taiwan ROC
  - Taichung, Taiwan ROC, Taiwan, 40201
    - Novartis Investigative Site
Turkey
- - Haydarpasa Istanbul, Turkey, 34668
    - Novartis Investigative Site
  - Istanbul, Turkey, 34304
    - Novartis Investigative Site
  - Izmir, Turkey, 35340
    - Novartis Investigative Site
  - Izmir, Turkey, 35000
    - Novartis Investigative Site
  - Mersin, Turkey, 33079
    - Novartis Investigative Site
  - Samsun, Turkey, 55090
    - Novartis Investigative Site
- Cankaya
  - Ankara, Cankaya, Turkey, 06100
    - Novartis Investigative Site
- Eskisehir
  - Meselik, Eskisehir, Turkey, 26480
    - Novartis Investigative Site
United Kingdom
- - Birmingham, United Kingdom, B9 5SS
    - Novartis Investigative Site
  - Bournemouth, United Kingdom, BH7 7DW
    - Novartis Investigative Site
  - Bristol, United Kingdom, BS2 8HN
    - Novartis Investigative Site
  - Cardiff, United Kingdom, CF64 2XX
    - Novartis Investigative Site
  - Chesterfield, United Kingdom, S40 4AA
    - Novartis Investigative Site
  - Edinburgh, United Kingdom, ED16 4SA
    - Novartis Investigative Site
  - Glasgow, United Kingdom, G20 7BE
    - Novartis Investigative Site
  - Harrow, United Kingdom, HA1 3UJ
    - Novartis Investigative Site
  - Leicester, United Kingdom, LE3 9QP
    - Novartis Investigative Site
  - Liverpool, United Kingdom, L7 8XP
    - Novartis Investigative Site
  - London, United Kingdom, W12 0HS
    - Novartis Investigative Site
  - Londonderry, United Kingdom, BT47 1SB
    - Novartis Investigative Site
  - Manchester, United Kingdom, M13 9NT
    - Novartis Investigative Site
  - Middlesbrough, United Kingdom, TS4 3BW
    - Novartis Investigative Site
  - Middlesex, United Kingdom, UB9 6JH
    - Novartis Investigative Site
  - Newcastle upon Tyne, United Kingdom, NE7 7DN
    - Novartis Investigative Site
  - Newport, United Kingdom, NP20 2UB
    - Novartis Investigative Site
  - Norwich, United Kingdom, NR4 7UY
    - Novartis Investigative Site
  - Plymouth, United Kingdom, PL6 8DH
    - Novartis Investigative Site
  - Sheffield, United Kingdom, S5 7AU
    - Novartis Investigative Site
  - Tyne And Wear, United Kingdom, NE29 8NH
    - Novartis Investigative Site
  - West Midlands, United Kingdom, B71 4HJ
    - Novartis Investigative Site
  - Wiltshire, United Kingdom, SN15 2SB
    - Novartis Investigative Site
  - Wrexham, United Kingdom, LL13 7TD
    - Novartis Investigative Site
- Cleveland
  - Stockton on Tees, Cleveland, United Kingdom, TS19 8PE
    - Novartis Investigative Site
- Dorset
  - Dorchester, Dorset, United Kingdom, DT1 2JY
    - Novartis Investigative Site
- GBR
  - London, GBR, United Kingdom, EC1M 6BQ
    - Novartis Investigative Site
- Greater London
  - London, Greater London, United Kingdom, EN3 4GS
    - Novartis Investigative Site
- Lancashire
  - Preston, Lancashire, United Kingdom, PR2 9QB
    - Novartis Investigative Site
- North Manchester
  - Rochdale, North Manchester, United Kingdom, OL11 4AU
    - Novartis Investigative Site
- Nothern Ireland
  - Portadown, Nothern Ireland, United Kingdom, BT63 5QQ
    - Novartis Investigative Site
- Perthshire
  - Dundee, Perthshire, United Kingdom, DD1 9SY
    - Novartis Investigative Site
- Somerset
  - Taunton, Somerset, United Kingdom, TA1 5DA
    - Novartis Investigative Site
- Surrey
  - Chertsey, Surrey, United Kingdom, KT160PZ
    - Novartis Investigative Site
- Swansea
  - Sketty, Swansea, United Kingdom, SA2 8PP
    - Novartis Investigative Site
- Tyne And Wear
  - Sunderland, Tyne And Wear, United Kingdom, SR4 7TP
    - Novartis Investigative Site
- Wales
  - Cardiff, Wales, United Kingdom, CF5 4AD
    - Novartis Investigative Site
  - Rhyl, Wales, United Kingdom, LL18 5UJ
    - Novartis Investigative Site
- West Sussex
  - Chichester, West Sussex, United Kingdom, PO19 6SE
    - Novartis Investigative Site
United States
- Alabama
  - Andalusia, Alabama, United States, 36420
    - Novartis Investigative Site
  - Birmingham, Alabama, United States, 35243
    - Novartis Investigative Site
  - Huntsville, Alabama, United States, 35801
    - Novartis Investigative Site
  - Mobile, Alabama, United States, 36608
    - Novartis Investigative Site
- Arizona
  - Cottonwood, Arizona, United States, 86326
    - Novartis Investigative Site
  - Gilbert, Arizona, United States, 85297
    - Novartis Investigative Site
  - Sun City West, Arizona, United States, 85375
    - Novartis Investigative Site
  - Tucson, Arizona, United States, 85745
    - Novartis Investigative Site
- Arkansas
  - Little Rock, Arkansas, United States, 72204
    - Novartis Investigative Site
- California
  - Beverly Hills, California, United States, 90211
    - Novartis Investigative Site
  - Beverly Hills, California, United States, 90210
    - Novartis Investigative Site
  - Covina, California, United States, 91723
    - Novartis Investigative Site
  - Huntington Beach, California, United States, 92648
    - Novartis Investigative Site
  - La Jolla, California, United States, 92037
    - Novartis Investigative Site
  - Long Beach, California, United States, 90806
    - Novartis Investigative Site
  - Los Angeles, California, United States, 90033
    - Novartis Investigative Site
  - Los Angeles, California, United States, 90073
    - Novartis Investigative Site
  - Northridge, California, United States, 91325
    - Novartis Investigative Site
  - Orange, California, United States, 92868
    - Novartis Investigative Site
  - San Diego, California, United States, 92103
    - Novartis Investigative Site
  - San Francisco, California, United States, 94115
    - Novartis Investigative Site
  - San Francisco, California, United States, 94158
    - Novartis Investigative Site
  - Santa Ana, California, United States, 92704
    - Novartis Investigative Site
  - Stanford, California, United States, 94305
    - Novartis Investigative Site
  - Stockton, California, United States, 95204
    - Novartis Investigative Site
  - West Hills, California, United States, 91307
    - Novartis Investigative Site
- Colorado
  - Aurora, Colorado, United States, 80045
    - Novartis Investigative Site
- Connecticut
  - Bridgeport, Connecticut, United States, 06610
    - Novartis Investigative Site
  - Hartford, Connecticut, United States, 06102-5037
    - Novartis Investigative Site
  - Waterbury, Connecticut, United States, 06708
    - Novartis Investigative Site
- Florida
  - Boca Raton, Florida, United States, 33434
    - Novartis Investigative Site
  - Bradenton, Florida, United States, 34209
    - Novartis Investigative Site
  - Brandon, Florida, United States, 33511
    - Novartis Investigative Site
  - Fort Lauderdale, Florida, United States, 33312
    - Novartis Investigative Site
  - Jacksonville, Florida, United States, 32205
    - Novartis Investigative Site
  - Jacksonville, Florida, United States, 32216
    - Novartis Investigative Site
  - Jacksonville, Florida, United States, 32223
    - Novartis Investigative Site
  - Miami, Florida, United States, 33133
    - Novartis Investigative Site
  - Naples, Florida, United States, 34102
    - Novartis Investigative Site
  - Port Charlotte, Florida, United States, 33952
    - Novartis Investigative Site
  - Port Orange, Florida, United States, 32127
    - Novartis Investigative Site
  - Saint Augustine, Florida, United States, 32086
    - Novartis Investigative Site
  - Wellington, Florida, United States, 33449
    - Novartis Investigative Site
- Georgia
  - Atlanta, Georgia, United States, 30322
    - Novartis Investigative Site
  - Atlanta, Georgia, United States, 30309
    - Novartis Investigative Site
  - Atlanta, Georgia, United States, 30084
    - Novartis Investigative Site
  - Atlanta, Georgia, United States, 30324
    - Novartis Investigative Site
  - Dunwoody, Georgia, United States, 30338
    - Novartis Investigative Site
  - Thomasville, Georgia, United States, 31792
    - Novartis Investigative Site
- Illinois
  - Chicago, Illinois, United States, 60612
    - Novartis Investigative Site
  - Park Ridge, Illinois, United States, 60068
    - Novartis Investigative Site
- Indiana
  - Indianapolis, Indiana, United States, 46202 4800
    - Novartis Investigative Site
- Iowa
  - Iowa City, Iowa, United States, 52242
    - Novartis Investigative Site
- Kansas
  - Kansas City, Kansas, United States, 66160
    - Novartis Investigative Site
  - Topeka, Kansas, United States, 66606
    - Novartis Investigative Site
- Louisiana
  - Alexandria, Louisiana, United States, 71301
    - Novartis Investigative Site
  - Baton Rouge, Louisiana, United States, 70808
    - Novartis Investigative Site
  - Bogalusa, Louisiana, United States, 70427
    - Novartis Investigative Site
  - Bossier City, Louisiana, United States, 71111
    - Novartis Investigative Site
  - Covington, Louisiana, United States, 70433
    - Novartis Investigative Site
  - Eunice, Louisiana, United States, 70535
    - Novartis Investigative Site
  - Hammond, Louisiana, United States, 70403
    - Novartis Investigative Site
  - Houma, Louisiana, United States, 70360
    - Novartis Investigative Site
  - Lafayette, Louisiana, United States, 70501
    - Novartis Investigative Site
  - Metairie, Louisiana, United States, 70006
    - Novartis Investigative Site
  - New Orleans, Louisiana, United States, 70112
    - Novartis Investigative Site
  - New Orleans, Louisiana, United States, 70115
    - Novartis Investigative Site
  - Opelousas, Louisiana, United States, 70570
    - Novartis Investigative Site
  - Shreveport, Louisiana, United States, 71101
    - Novartis Investigative Site
  - Shreveport, Louisiana, United States, 71105
    - Novartis Investigative Site
  - Slidell, Louisiana, United States, 70458
    - Novartis Investigative Site
  - Zachary, Louisiana, United States, 70791
    - Novartis Investigative Site
- Maine
  - Scarborough, Maine, United States, 04074
    - Novartis Investigative Site
- Maryland
  - Baltimore, Maryland, United States, 21201
    - Novartis Investigative Site
  - Baltimore, Maryland, United States, 21287
    - Novartis Investigative Site
  - Baltimore, Maryland, United States, 21209
    - Novartis Investigative Site
  - Columbia, Maryland, United States, 21044
    - Novartis Investigative Site
  - Fort Washington, Maryland, United States, 20744
    - Novartis Investigative Site
  - Rockville, Maryland, United States, 20850
    - Novartis Investigative Site
- Massachusetts
  - Boston, Massachusetts, United States, 02115
    - Novartis Investigative Site
  - Boston, Massachusetts, United States, 02114-2696
    - Novartis Investigative Site
- Michigan
  - Detroit, Michigan, United States, 48202
    - Novartis Investigative Site
  - Detroit, Michigan, United States, 48201
    - Novartis Investigative Site
  - Flint, Michigan, United States, 48504
    - Novartis Investigative Site
  - Grand Blanc, Michigan, United States, 48439
    - Novartis Investigative Site
  - Kalamazoo, Michigan, United States, 49008
    - Novartis Investigative Site
  - Petoskey, Michigan, United States, 49770
    - Novartis Investigative Site
  - Saginaw, Michigan, United States, 48601
    - Novartis Investigative Site
  - Wyoming, Michigan, United States, 49519
    - Novartis Investigative Site
- Minnesota
  - Maplewood, Minnesota, United States, 55109
    - Novartis Investigative Site
  - Minneapolis, Minnesota, United States, 55455
    - Novartis Investigative Site
  - Minneapolis, Minnesota, United States, 55407
    - Novartis Investigative Site
- Mississippi
  - Belzoni, Mississippi, United States, 39038
    - Novartis Investigative Site
  - Southaven, Mississippi, United States, 38671
    - Novartis Investigative Site
  - Yazoo City, Mississippi, United States, 39194
    - Novartis Investigative Site
- Missouri
  - Saint Louis, Missouri, United States, 63110
    - Novartis Investigative Site
  - Saint Louis, Missouri, United States, 63141
    - Novartis Investigative Site
  - Saint Louis, Missouri, United States, 63128
    - Novartis Investigative Site
  - Saint Peters, Missouri, United States, 63303
    - Novartis Investigative Site
- Nebraska
  - Lincoln, Nebraska, United States, 68526
    - Novartis Investigative Site
  - Omaha, Nebraska, United States, 68114
    - Novartis Investigative Site
  - Omaha, Nebraska, United States, 68134
    - Novartis Investigative Site
- New Hampshire
  - Lebanon, New Hampshire, United States, 03756
    - Novartis Investigative Site
- New Jersey
  - Ridgewood, New Jersey, United States, 07450
    - Novartis Investigative Site
  - Summit, New Jersey, United States, 07901
    - Novartis Investigative Site
- New York
  - Albany, New York, United States, 12206
    - Novartis Investigative Site
  - Manhasset, New York, United States, 11030
    - Novartis Investigative Site
  - New York, New York, United States, 10016
    - Novartis Investigative Site
  - New York, New York, United States, 10029
    - Novartis Investigative Site
  - New York, New York, United States, 10021
    - Novartis Investigative Site
  - New York, New York, United States, 10075
    - Novartis Investigative Site
  - New York, New York, United States, 43210
    - Novartis Investigative Site
  - Rochester, New York, United States, 14642
    - Novartis Investigative Site
  - Rochester, New York, United States, 14621
    - Novartis Investigative Site
  - Southampton, New York, United States, 11968
    - Novartis Investigative Site
- North Carolina
  - Charlotte, North Carolina, United States, 28204
    - Novartis Investigative Site
  - Greensboro, North Carolina, United States, 27408
    - Novartis Investigative Site
  - Greensboro, North Carolina, United States, 27405
    - Novartis Investigative Site
  - High Point, North Carolina, United States, 27262
    - Novartis Investigative Site
  - Raleigh, North Carolina, United States, 27609
    - Novartis Investigative Site
  - Sanford, North Carolina, United States, 27330
    - Novartis Investigative Site
  - Shelby, North Carolina, United States, 28150
    - Novartis Investigative Site
  - Winston-Salem, North Carolina, United States, 27157
    - Novartis Investigative Site
- Ohio
  - Akron, Ohio, United States, 44304
    - Novartis Investigative Site
  - Akron, Ohio, United States, 44309
    - Novartis Investigative Site
  - Canton, Ohio, United States, 44710
    - Novartis Investigative Site
  - Cincinnati, Ohio, United States, 45267
    - Novartis Investigative Site
  - Cincinnati, Ohio, United States, 45219
    - Novartis Investigative Site
  - Cincinnati, Ohio, United States, 45246
    - Novartis Investigative Site
  - Cleveland, Ohio, United States, 44195
    - Novartis Investigative Site
  - Columbus, Ohio, United States, 43210
    - Novartis Investigative Site
  - Marion, Ohio, United States, 43302
    - Novartis Investigative Site
- Oregon
  - Portland, Oregon, United States, 97239
    - Novartis Investigative Site
- Pennsylvania
  - Lancaster, Pennsylvania, United States, 17603
    - Novartis Investigative Site
  - Philadelphia, Pennsylvania, United States, 19104
    - Novartis Investigative Site
  - Pittsburgh, Pennsylvania, United States, 15212
    - Novartis Investigative Site
  - Yardley, Pennsylvania, United States, 19067
    - Novartis Investigative Site
- Rhode Island
  - Providence, Rhode Island, United States, 02906
    - Novartis Investigative Site
- South Carolina
  - Fort Mill, South Carolina, United States, 29707
    - Novartis Investigative Site
  - Summerville, South Carolina, United States, 29485
    - Novartis Investigative Site
- South Dakota
  - Rapid City, South Dakota, United States, 57701
    - Novartis Investigative Site
- Tennessee
  - Germantown, Tennessee, United States, 38138
    - Novartis Investigative Site
  - Jackson, Tennessee, United States, 38301
    - Novartis Investigative Site
  - Knoxville, Tennessee, United States, 37917
    - Novartis Investigative Site
  - Nashville, Tennessee, United States, 37232
    - Novartis Investigative Site
  - Powell, Tennessee, United States, 37849
    - Novartis Investigative Site
- Texas
  - Dallas, Texas, United States, 75235
    - Novartis Investigative Site
  - Dallas, Texas, United States, 75226
    - Novartis Investigative Site
  - Dallas, Texas, United States, 75231
    - Novartis Investigative Site
  - Dallas, Texas, United States, 75390
    - Novartis Investigative Site
  - Houston, Texas, United States, 77030
    - Novartis Investigative Site
  - Livingston, Texas, United States, 77351
    - Novartis Investigative Site
  - Marshall, Texas, United States, 75670
    - Novartis Investigative Site
  - Temple, Texas, United States, 76508
    - Novartis Investigative Site
  - Tomball, Texas, United States, 77375
    - Novartis Investigative Site
- Utah
  - Bountiful, Utah, United States, 84010
    - Novartis Investigative Site
  - Layton, Utah, United States, 84041
    - Novartis Investigative Site
  - Murray, Utah, United States, 84107
    - Novartis Investigative Site
  - Salt Lake City, Utah, United States, 84132
    - Novartis Investigative Site
- Virginia
  - Danville, Virginia, United States, 24541
    - Novartis Investigative Site
  - Falls Church, Virginia, United States, 22042
    - Novartis Investigative Site
  - Manassas, Virginia, United States, 20109
    - Novartis Investigative Site
  - Norfolk, Virginia, United States, 23510
    - Novartis Investigative Site
  - Richmond, Virginia, United States, 23219
    - Novartis Investigative Site
- Washington
  - Seattle, Washington, United States, 98104
    - Novartis Investigative Site
  - Seattle, Washington, United States, 98122
    - Novartis Investigative Site
  - Seattle, Washington, United States, 98195
    - Novartis Investigative Site
- West Virginia
  - Morgantown, West Virginia, United States, 26506
    - Novartis Investigative Site
- Wisconsin
  - Milwaukee, Wisconsin, United States, 53215
    - Novartis Investigative Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Description

Key Inclusion Criteria

Lp(a) ≥ 70 mg/dL at the screening visit, measured at the Central laboratory
Myocardial infarction: ≥ 3 months from screening and randomization to ≤ 10 years prior to the screening visit
Ischemic stroke: ≥ 3 months from screening and randomization to ≤ 10 years prior to the screening visit
Clinically significant symptomatic peripheral artery disease

Key Exclusion Criteria

Uncontrolled hypertension
Heart failure New York Heart Association (NYHA) class IV
History of malignancy of any organ system
History of hemorrhagic stroke or other major bleeding
Platelet count ≤LLN
Active liver disease or hepatic dysfunction
Significant kidney disease
Pregnant or nursing women

Other protocol-defined inclusion/exclusion criteria may apply at the end.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Interventional Model: Parallel Assignment
Masking: Double

Number of Arms

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: TQJ230 TQJ230 80 mg injected monthly administered subcutaneously	Drug: TQJ230 TQJ230 80 mg injected monthly administered subcutaneously
Placebo Comparator: Placebo Monthly subcutaneous injections.	Drug: Placebo Placebo to match TQJ230 prefilled syringe to be injected subcutaneously Other Names: Placebo to match TQJ230

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Time to first occurrence of clinical endpoint committee confirmed expanded major adverse cardiovascular events in patients with elevated Lp(a) ≥ 70 mg/dL Time Frame: approximately 4 years	Demonstrate the superiority of pelacarsen (TQJ230) compared to placebo in reducing the risk of expanded MACE (cardiovascular death, non-fatal MI, non-fatal stroke and urgent coronary re-vascularization requiring hospitalization) in the overall study population with established CVD and (Lp(a) ≥ 70 mg/dL)	approximately 4 years
Time to the first occurrence of clinical endpoint committee confirmed expanded major adverse cardiovascular events in a population of patients with elevated Lp(a) ≥ 90 mg/dL. Time Frame: approximately 4 years	Demonstrate the superiority of pelacarsen (TQJ230) compared to placebo in reducing the risk of expanded MACE (cardiovascular death, non-fatal MI, non-fatal stroke and urgent coronary re-vascularization requiring hospitalization) in the overall study population with established CVD and (Lp(a) ≥ 90 mg/dL)	approximately 4 years

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Time to the first occurrence of the clinical endpoint committee confirmed composite endpoint of major adverse cardiovascular events (CV death, non-fatal MI, and non-fatal stroke) Time Frame: approximately 4 years	Demonstrate the superiority of pelacarsen (TQJ230) compared to placebo in reducing the risk of the MACE composite of CV death, nonfatal MI and non-fatal stroke.	approximately 4 years
Time to the first occurrence of the clinical endpoint committee confirmed composite endpoint of coronary heart disease: coronary heart disease death, non-fatal MI, urgent coronary re-vascularization requiring hospitalization Time Frame: approximately 4 years	Demonstrate the superiority of pelacarsen (TQJ230) compared to placebo in reducing the risk of the composite of coronary heart disease (CHD) outcomes: death due to CHD, nonfatal MI and urgent coronary revascularization requiring hospitalization.	approximately 4 years
Number of participants with confirmed all-cause death Time Frame: approximately 4 years	Evaluation by clinical endpoint committee the rate of all-cause death	approximately 4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Novartis Pharmaceuticals

Investigators

Study Director: Novartis Pharmaceuticals, Novartis Pharmaceuticals

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2019

Primary Completion (Estimated)

May 29, 2025

Study Completion (Estimated)

May 30, 2025

Study Registration Dates

First Submitted

July 16, 2019

First Submitted That Met QC Criteria

July 16, 2019

First Posted (Actual)

July 17, 2019

Study Record Updates

Last Update Posted (Estimated)

November 14, 2023

Last Update Submitted That Met QC Criteria

November 13, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Keywords

Lipoprotein(a), Lp(a),CVD, myocardial infarction, PAD,Stroke, Pelacarsen

Additional Relevant MeSH Terms

Cardiovascular Diseases

Other Study ID Numbers

CTQJ230A12301 (Other Identifier: Novartis)
2019-001076-11 (EudraCT Number)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Novartis is committed to sharing with qualified external researchers, access to patient -level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with the applicable laws and regulations.

This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Disease and Lipoprotein(a)

Novartis Pharmaceuticals

Completed

Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

Cardiovascular Disease and Lipoprotein(a)

China, Germany, United States, Colombia, South Africa, Italy, Spain, Belgium, Egypt, Hungary, Taiwan, Turkey, Japan, Netherlands, Australia, Austria, Canada, Czechia, France, Israel, Switzerland, United Kingdom, Korea, Republic of, Th... and more
Akcea Therapeutics

Completed

Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Warfarin

Cardiovascular Diseases | Elevated Lipoprotein(a)

Canada
Akcea Therapeutics

Completed

Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Clopidogrel

Cardiovascular Diseases | Elevated Lipoprotein(a)

Canada
Ionis Pharmaceuticals, Inc.
Akcea Therapeutics

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS APO(a)-LRx in Healthy Volunteers With Elevated Lipoprotein(a)

Elevated Lipoprotein(a)

Canada
Ionis Pharmaceuticals, Inc.

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS-APO(a)Rx in Participants With High Lipoprotein(a)

Elevated Lipoprotein(a)

Netherlands, United Kingdom, Denmark, Germany, Canada
Akcea Therapeutics
Ionis Pharmaceuticals, Inc.

Completed

Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease

Cardiovascular Disease | Elevated Lipoprotein(a)

United States, Canada, Denmark, Germany, Netherlands
Amgen

Completed

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a)

Elevated Serum Lipoprotein(a)

Hong Kong
Charite University, Berlin, Germany

Unknown

Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study) (NICOLa)

Elevated Lipoprotein(a) Levels

Germany
Silence Therapeutics plc

Active, not recruiting

Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events

Cardiovascular Diseases | Atherosclerosis | Lipoprotein(a)

Australia, Czechia, Denmark, Netherlands, Slovakia, South Africa, United Kingdom
Changi General Hospital

Not yet recruiting

Elevated Lipoprotein(a) in Hospital Staff (LPACO)

Cardiovascular Diseases | Hypercholesterolemia | Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia

Singapore

Clinical Trials on TQJ230

Novartis Pharmaceuticals

Recruiting

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Aortic Stenosis

Israel, United Kingdom
Novartis Pharmaceuticals

Completed

Study to Assess the Pharmacokinetics of Pelacarsen (TQJ230) in Participants With Mild Hepatic Impairment Compared to Matched Healthy Participants

Hepatic Impairment

United States
Novartis Pharmaceuticals

Active, not recruiting

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany

Hyperlipoproteinemia(a)

Germany
Novartis Pharmaceuticals

Not yet recruiting

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals

Recruiting

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) (OLE)

Hyperlipoproteinemia (a)

Germany
University Medical Centre Ljubljana

Withdrawn

Influence of Pelacarsen on Patients After Myocardial Infarction With High Lp(a) Values (PEMILA)

Inflammation | Acute Coronary Syndrome | Lipoproteinemia | Genetic Polymorphisms

Slovenia
Ionis Pharmaceuticals, Inc.

Completed

A Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pelacarsen (ISIS 681257) in Healthy Japanese Participants

Healthy Participants

United States
Akcea Therapeutics
Ionis Pharmaceuticals, Inc.

Completed

Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease

Cardiovascular Disease | Elevated Lipoprotein(a)

United States, Canada, Denmark, Germany, Netherlands

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD (Lp(a)HORIZON)

A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease

Study Overview

Status

Conditions

Intervention / Treatment

Study Type

Enrollment (Actual)

Phase

Contacts and Locations

Study Locations

Participation Criteria

Eligibility Criteria

Ages Eligible for Study

Accepts Healthy Volunteers

Description

Study Plan

How is the study designed?

Design Details

Number of Arms

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure

Measure Description

Time Frame

Secondary Outcome Measures

Outcome Measure

Measure Description

Time Frame

Collaborators and Investigators

Sponsor

Investigators

Publications and helpful links

General Publications

Study record dates

Study Major Dates

Study Start (Actual)

Primary Completion (Estimated)

Study Completion (Estimated)

Study Registration Dates

First Submitted

First Submitted That Met QC Criteria

First Posted (Actual)

Study Record Updates

Last Update Posted (Estimated)

Last Update Submitted That Met QC Criteria

Last Verified

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

IPD Plan Description

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Studies a U.S. FDA-regulated device product

Clinical Trials on Cardiovascular Disease and Lipoprotein(a)

Clinical Trials on TQJ230

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations